Cyfendus Anthrax Vaccine Wins FDA Approval
XTalks
JULY 25, 2023
Cyfendus functions by stimulating the production of antibodies targeted against the protective antigen protein. Efficacy of Cyfendus The FDA approval of the Cyfendus anthrax vaccine is grounded in a series of studies supported by the US government and carried out by Emergent. Overall, 66.3 on Day 64 in the study.
Let's personalize your content